Investment
Features
FeesSafety
Academy
More
Pluang+

Focus Graphite secures C$2M credit line to support government-funded graphite projects.

Company Fundamentals
14 Sep 2026
Newsfile Corp
View Source
Bullish
Focus Graphite secures C$2M credit line to support government-funded graphite projects.

Focus Graphite Inc. has established a secured revolving credit facility of up to C$2 million with CIBC to support working capital needs for its graphite projects. This facility helps bridge the timing gap between project expenditures and government reimbursements from over C$15 million in non-dilutive federal funding. The credit line provides financial flexibility without issuing new shares, aiding the advancement of the Lac Knife Graphite Project and related infrastructure in Quebec. Focus plans to use the facility as a short-term liquidity bridge while continuing to develop its graphite resources and technologies.

More News

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...

Market News
Bullish
33 minutes ago
WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...

Market News
Bullish
33 minutes ago
IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...

Market News
Bullish
33 minutes ago
Sika to acquire Resonac's adhesives business, boosting growth in Asian automotive markets.

Sika to acquire Resonac's adhesives business, boosting growth in Asian automotive markets.

Sika AG has agreed to acquire the adhesives business of Japan's Resonac Corporation, which serves automotive customers across Asia. This acquisition will expand Sika's access to key Japanese automotive OEM suppliers and broaden its product offerings,...

Company Fundamentals
Bullish
33 minutes ago
Hudbay and Mitsubishi approve Copper World project, aiming for U.S. copper mine production by 2029

Hudbay and Mitsubishi approve Copper World project, aiming for U.S. copper mine production by 2029

Hudbay and Mitsubishi have approved the construction of the Copper World project, a major new copper mine in the U.S. This project is significant as it advances the development of a key resource mine, with production expected to begin in 2029. The ap...

Market News
Bullish
33 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App